-
80 per cent of all smokers live in low and middle-income countries, India one among it: WHO
NEW DELHI: Nearly 80 per cent of the over one billion tobacco smokers globally live in low- and middle-income countries like India, WHO said today and asserted that policies to control its use, including taxation and price increase, can generate revenues for health care and development work.
- Categories
- Health Care
- Region
- South Asia
- Tags
- public policy
-
This 20-cent whirligig toy can replace a $1,000 medical centrifuge
Centrifuges, which separate materials in fluids by spinning them at great speed, are found in medical labs worldwide. But a good one could run you a couple grand and, of course, requires electricity — neither of which are things you’re likely to find in a rural clinic in an impoverished country.
- Categories
- Health Care
-
Scientist makes improvements to surgical masks
A Scientist at the University of Alberta has found a way to improve one of the most fundamental pieces of medical equipment, and he did it using something you’d find on your kitchen table.
- Categories
- Health Care
- Region
- North America
-
Viewpoint: Embracing Digital Healthcare in Kenya
The digital revolution is upon us. Over the years we have seen technology become embedded across many industries ranging from banking, telecommunications, retail, insurance and even Government. Kenya is no stranger to this digital revolution, with mobile money platforms allowing those who were previously financially disenfranchised access to financial services.
- Categories
- Health Care, Technology
- Region
- Sub-Saharan Africa
-
Nigeria: New Malaria Vaccine Shows Efficacy, Safety in Humans
A next-generation vaccine that uses a weakened form of a malaria parasite has shown efficacy and safety in a small number of humans, according to a new study published in Science Translational Medicine. With this development researchers of the vaccine called GAP3KO might have achieved a milestone in malaria vaccine development.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- public health
-
Merck’s Vaccine Won’t Be the End of Ebola
An Ebola vaccine that has been in development for 15 years has been shown in a clinical trial to be up to 100 percent effective at preventing the deadly virus. But it won’t stop sporadic cases from popping up, nor will it be immediately available to some who are most vulnerable to the virus.
- Categories
- Health Care
-
Opinion: Global health is good business — Trump should get in the prosperity
As President-elect Trump considers submitting a fiscal year 2018 budget request to Congress, scores of government funding issues will be intensely debated. America’s investment in global health is one area that should stand outside the political fray.
- Categories
- Health Care, Investing
- Region
- North America
- Tags
- impact investing
-
Mamaope, Uganda’s Lifesaving Jacket
According to UNICEF, in Sub-Saharan Africa, pneumonia kills half a million children aged five and below every year; this accounts for half of all global deaths of children under five from pneumonia. But unlike HIV/AIDS and measles, pneumonia does not get the attention it needs to be prevented, managed, and treated. This despondent fact inspired a young Ugandan boy to become a beam of hope to thousands of kids who are left at the mercy of this disease, through the invention of a biochemical smart jacket, which detects pneumonia 3 to 4 times faster than the orthodox doctors’ detection. This life jacket, that will save thousands of children yearly, is called “Mamaope” or “Mother’s hope”, in tribute to the 27,000 Ugandan kids that lose their fight to Pneumonia yearly in Uganda.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
Subscribe to Our 'Business in Global Development' Newsletter!
Our new weekly LinkedIn newsletter features NextBillion's latest original articles, along with curated news, jobs, bizdev opportunities and events from our recent coverage of impact-focused business in emerging markets.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.